Refractory status epilepticus in children: When do we stop treatment? [7]

European Neurology

Volumn 59, Issue 1-2, 2007, Pages 94-95

  Sethi, N K ^a   Torgovnick, J ^b   Arsura, E ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; CORTICOSTEROID; ETIRACETAM; IMMUNOGLOBULIN; ISOFLURANE; KETAMINE; LAMOTRIGINE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXINE; TOPIRAMATE;

CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; ELECTROENCEPHALOGRAM; ELECTROGRAPHY; ENDOTRACHEAL INTUBATION; EPILEPTIC STATE; GRAND MAL EPILEPSY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KETOGENIC DIET; LETTER; LOADING DRUG DOSE; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT DURATION;

CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; STATUS EPILEPTICUS; TIME FACTORS; TREATMENT FAILURE;

EID: 37249019966     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109577     Document Type: Letter

References (2)

1. Sayers GM, Perera S: Withholding life prolonging treatment and self-deception. J Med Ethics 2002;28:347-352.
2. Burns JP, Mitchell C: Is there any consensus about end of life care in pediatrics? Arch Pediatr Adolesc Med 2005;159:889-891.